Market Analysis and Insights: Global Fibrinogen Concentrate Market

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc.

Due to the COVID-19 pandemic, the global Fibrinogen Concentrate market size is estimated to be worth US$ 796 million in 2022 and is forecast to a readjusted size of US$ 2207.6 million by 2029 with a CAGR of 15.5% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Human Fibrinogen Concentrate accounting for % of the Fibrinogen Concentrate global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Surgical Procedures segment is altered to an % CAGR throughout this forecast period.

The major producers in the industry are CSL Behring, LFB Group and Shanghai RAAS Blood Products, whose revenue ratios in 2019 are 52.52%, 20.36% and 10.02% respectively.

Global Fibrinogen Concentrate Scope and Market Size

The global Fibrinogen Concentrate market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Fibrinogen Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Human Fibrinogen Concentrate

Others


Segment by Application


Surgical Procedures

Congenital Fibrinogen Deficiency

Others

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


CSL Behring

LFB

Shanghai RAAS

Boya

Hualan Biological Engineering

Harbin Pacific Biopharmaceutical

Greencross

Shanghai XinXing Medical

Octapharma